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FEM proteinsssential and conserved function in establishing polarity in many cell types and
organisms. However, their key upstream regulators remain to be identiﬁed. In C. elegans, regulators of the
PAR proteins can be identiﬁed by their ability to suppress the lethality of par-2 mutant embryos. Here we
show that a nos-3 loss of function mutant suppresses the lethality of par-2 mutants by regulating PAR-6
protein levels. The suppression requires the activity of the sex determination genes fem-1/2/3 and of the
cullin cul-2. FEM-1 is a substrate-speciﬁc adaptor for a CUL-2-based ubiquitin ligase (CBCFEM-1). Interestingly,
we ﬁnd that CUL-2 is required for the regulation of PAR-6 levels and that PAR-6 physically interacts with
FEM-1. Our data strongly suggest that PAR-6 levels are regulated by the CBCFEM-1 ubiquitin ligase thereby
uncovering a novel role for the FEM proteins and cullin-dependent degradation in regulating PAR proteins
and polarity processes.
© 2008 Elsevier Inc. All rights reserved.IntroductionCell polarity is a property of many cells important for processes
such as differentiation and morphogenesis. In particular, establish-
ment of a polarity axis is an essential prerequisite for asymmetric cell
division, a fundamental process that generates cell diversity during
the development of metazoans (Betschinger and Knoblich, 2004).
Work in several model organisms demonstrated that the conserved
PAR (partitioning-defective) proteins play a fundamental role in
establishing and maintaining polarity in many cell types, including
asymmetrically dividing cells but also nondividing cell types (Suzuki
and Ohno, 2006).
The C. elegans embryo is an excellent model system to study
establishment of a polarity axis and asymmetric cell division. The ﬁrst
division of the embryo is asymmetric resulting in two cells that are
different in size and fate. This asymmetric division relies on the
establishment of an antero-posterior polarity axis in the one-cell
embryo. Proper establishment of this axis requires the PAR proteins
(PAR-1 to -6 and PKC-3) (Kemphues et al., 1988; Suzuki and Ohno,
2006). In the one-cell embryo, PAR proteins deﬁne an anterior and a
posterior cortical domain: PAR-3 and PAR-6, two PDZ containing
proteins, and PKC-3, an atypical protein kinase C, are localized at the
anterior cortex of the embryo (Etemad-Moghadam et al., 1995; Hungicine and Development, 1 rue
. Gotta).
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l rights reserved.and Kemphues, 1999; Tabuse et al., 1998a), while PAR-1, a serine–
threonine kinase, and PAR-2, a ring ﬁnger containing protein, are res-
tricted to the posterior cortex (Boyd et al., 1996; Guo and Kemphues,
1995).
Although the essential function of PAR proteins in establi-
shing polarity is conserved, the mechanisms controlling PAR pro-
tein levels and asymmetric distribution are still not fully under-
stood. In the early C. elegans embryo, asymmetric localization of
PAR proteins occurs in two steps (Cuenca et al., 2003). First, ante-
riorly directed cortical ﬂows result in the accumulation of PAR-3,
PAR-6 and PKC-3 at the anterior cortex (Cheeks et al., 2004; Cowan
and Hyman, 2007; Munro et al., 2004). Second, accumulation of
PAR-2 at the posterior cortex maintains this asymmetric distribution
of the anterior PARs (Cheeks et al., 2004; Cuenca et al., 2003; Hao
et al., 2006).
In par-2 mutant embryos the anterior PAR proteins spread
towards the posterior, leading to polarity defects and embryonic
lethality (Etemad-Moghadam et al., 1995; Hung and Kemphues,
1999; Kemphues et al., 1988; Tabuse et al., 1998b). Interestingly,
reduction of PAR-6, PAR-3 or PKC-3 levels in a par-2 mutant back-
ground is sufﬁcient to suppress par-2 polarity defects and lethality
(Labbe et al., 2006; Watts et al., 1996). We recently found that a
nos-3 mutant, nos-3(q650), suppresses par-2(it5) lethality and
polarity defects and restores the asymmetric localization of PAR-3
and PAR-6 (Labbe et al., 2006). nos-3 is one of the three C. elegans
homologues of Nanos, a translational repressor involved in estab-
lishing the antero-posterior axis in early Drosophila embryos (Wang
and Lehmann, 1991). In C. elegans, NOS-3 has been proposed to
repress the translation of fem-3, a gene involved in sex deter-
Fig. 1. Suppression of par-2(it5) phenotypes by nos-3(q650) requires fem-3. (A, B)
Suppression of par-2(it5) embryonic lethality (A) and polarity defects (B) by nos-3(q650)
is strongly inhibited in nos-3(q650);par-2(it5);fem-3(e2006) triple mutant. Embryonic
lethality was assessed by counting more than 500 progeny of each genotype. (B) In
wild-type 2-cell embryos, the anterior blastomere (AB) is bigger than the posterior
blastomere (P1), AB and P1 divide asynchronously, the nucleo-centrosomal complex
rotates in P1, which results in the AB and P1 mitotic spindles being perpendicular to
each other, and PAR-6 is localized at the cortex of AB. In par-2(it5) embryos, AB and P1
have the same size, divide synchronously, nucleo-centrosomal complex rotation in P1
does not occur and PAR-6 is localized at both AB and P1 cortices. Asymmetry in size
was evaluated by measuring AB length/total embryo length ratio after completion of
the ﬁrst cytokinesis. Delay between AB and P1 cytokinesis in par-2(it5) mutants
ranged from 0 to 60 s. Division was considered asynchronous when the delay between
AB and P1 cytokinesis was higher than 60 s. Position of the P1 spindle was measured
just after nuclear envelope breakdown, alignment along the antero-posterior axis
corresponds to 0°. On the graph, one short bar represents one embryo. The length of
each bar is proportional to the number of embryos scored for a given angle. Anterior is
to the left. Arrowheads in the DIC images indicate the spindle poles. n is the number
of embryos analyzed.
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the suppression of par-2(it5) phenotypes in nos-3(q650);par-2(it5)
embryos requires the activity of the sex determination factors
FEM-1/2/3. Recently, FEM-1 has been shown to be a substrate-
speciﬁc adaptor for a CUL-2/ElonginB/C based ubiquitin ligase
referred to as CBCFEM-1, for the components CUL-2, Elongin B and
Elongin C (Kamura et al., 2004; Starostina et al., 2007). Consistent
with this, cul-2 is also required for the suppression of par-2(it5) by
nos-3(q650). Interestingly we ﬁnd that NOS-3 suppresses par-2 phe-
notypes by regulating PAR-6 levels in a CUL-2 dependent manner.
Together with the observation that the substrate-speciﬁc adaptor
FEM-1 physically interacts with PAR-6, our data strongly suggest
that the CBCFEM-1 ubiquitin ligase negatively regulates PAR-6 by
promoting its degradation.
Materials and methods
Strains
The wild-type strain was the N2 (Bristol) strain. The alleles used in this study were
LGII: nos-3(q650) (Kraemer et al., 1999); LGIII: par-2(it5ts) (Kemphues et al., 1988);
LGIV: fem-3(e2006) (Hodgkin, 1986). For the pie-1::GFP::PAR-6 transgene, PAR-6
cDNA was cloned into pID3.01 (Pellettieri et al., 2003). All strains were maintained at
15 °C as described except the nos-3(q650);GFP::PAR-6 strain which was maintained
at 22 °C.
RNAi and suppression assays
par-2, fem-1 and fem-2 RNAi constructs are as previously described (Kamath et al.,
2003). cul-2 and fem-3 RNAi constructs were obtained from L. Pintard and C. Eckmann.
For all RNAi constructs the genes were cloned into the L4440 vector (Timmons and Fire,
1998).
Embryonic lethality was assessed 24 h after removing adult worms from plates,
dividing the number of nonhatched embryos by the total number of progeny.
Since we could not obtain a par-2(it5);GFP::PAR-6 strain, inactivation of par-2 in
nos-3(q650);GFP::PAR-6 was done by injecting par-2 dsRNA in nos-3(q650);GFP::
PAR-6. Adult worms were grown at 22 °C, singled 24 h and removed 48 h post-
injection. Analysis of nos-3(q650);par-2(it5);fem-3(e2006) triple mutants was done by
shifting L4 larvae to 25 °C. fem-1, fem-2 and fem-3 RNAi was performed by injection.
Adult worms were grown at 25 °C, singled 18 h and removed 48 h post-injection. For
cul-2(RNAi) experiments L1 larvaewere grown onOP50 for 60 h at 15 °C and then shifted
to 20 °C. After 72 h worms were washed and transferred to feeding plates (1 mM IPTG).
Worms were removed after 83 h.
The experiments in each panel were performed in parallel and with the same
conditions.
Microscopy
DIC time-lapse images were acquired by an Orca ER Hamamatsu CCD camera,
mounted on a Zeiss Axiovert 200 microscope. Images were acquired at 10 s intervals
using the Openlab software (Improvision Ltd.).
For immunoﬂuorescence analysis, embryos were ﬁxed in methanol and stained
according to standard procedures with rabbit anti-PAR-6 antibodies (Labbe et al., 2006)
and Alexa568-coupled goat-anti-rabbit secondary antibodies (Molecular Probes).
Images were acquired using a Leica SP2 confocal microscope.
Western blot analysis
nos-3(q650) and nos-3(q650);GFP::PAR-6 worms were grown at 25 °C. For control
(L4440) and cul-2 RNAi in N2 and nos-3(q650), L1 larvae were grown for 24 h at 25 °C on
NA22, washed and transferred on 1 mM IPTG feeding plates for 27 h.
Embryos were collected by bleaching adult hermaphrodites, resuspended in SDS-
sample buffer and heated 5 min at 95 °C. The following antibodies were used: rabbit
anti-PAR-6 and anti-PAR-3 (Labbe et al., 2006), rabbit anti-PKC-3 (raised to aa 1 to 229
of PKC-3 fused to GST), mouse anti-tubulin (DM1A, Roche), mouse anti-HA (HA.11,
Covance), mouse anti-Flag (M2, Sigma) and secondary antibodies coupled to HRP (Bio-
Rad). To measure protein amounts semi-quantitatively, ﬁlms were scanned and signal
intensity measured with the Quantity One software (Bio-Rad). Total signal intensities
of nonsaturated bands were measured and the background subtracted. The ratio PAR/
tubulin was normalized to 100 in control samples. For Figs. 4A–C, results were
obtained from 4 independent extracts and 9 blots. For Fig. 6, experiments were
performed in parallel and results were obtained from 2 independent extracts and 6
blots.
Cell culture, transfections, immunoprecipitations
For expression in Drosophila S2 cells, C. elegans par-6 cDNA was cloned into pAc5.1
(Invitrogen), fem-1, fem-2, fem-3 and mex-5 cDNAs into pAHW and pAFW (DrosophilaGateway Vector Collection, N-terminal HA-tag). For immunoprecipitations, S2 cells
were transfected with the FuGENE 6 reagent 48 h before cell extraction and, for Figs.
7A, B, incubated 6 h with proteasome inhibitor (MG132, 50 μM). Extracts were
performed in 20 mM Tris pH 7.5, 100 mM NaCl, 5 mM MgCl2, 0.2% NP40, 10% glycerol,
1 mM NaF, 20 mM β-glycerophosphate, 0.5 mM DTT and Complete Protease Inhibitor
(Roche). Immunoprecipitations were performed with anti-PAR-6 antibody (Labbe et al.,
2006) (Figs. 7A, B) or anti-HA antibody (Fig. 2A), and protein A beads (Biorad). Beads
were preincubated with antibody for 2 h, incubated 2 h with cell extracts and washed
with TBS-Tween-20 (0.05%) and IP buffer (20 mM Tris pH 7.5, 150 mM NaCl, 5 mM
MgCl2, 0.1% NP40, 5% glycerol, 20 mM β-glycerophosphate, 0.5 mM DTT and Complete
Protease Inhibitor (Roche)).
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For the in vitro binding assay, fem-1, zif-1 and mex-5 cDNAs were cloned into
pDEST-15 (Invitrogen, N-terminal GST fusion). The HIS-PAR-6 construct was described
in Hung and Kemphues (1999). GST-FEM-1, GST-ZIF-1, GST-MEX-5 and HIS-PAR-6 were
expressed in the C41 E. Coli strain grown in LB+150 mM NaCl and 5% Glycerol and
induced with 0.5 mM IPTG (4 h at 16 °C). Bacteria expressing GST-tagged proteins were
lysed in 50 mM Tris pH7.5, 500 mM NaCl, 0.05% NP40, 2 mM DTT, 1 mM EDTA, 10%
glycerol and protease cocktail inhibitor (Roche). Lysates were incubated overnight with
glutathione sepharose 4B beads at 4 °C. Bound proteins were washed 5 times in the
same buffer. Bacteria expressing HIS-PAR-6 were lysed in 50 mM NaH2PO4, pH 8,
300 mM NaCl, 0.05% NP-40, 2 mM DTT and protease cocktail inhibitor (Roche). Lysates
were incubated with Ni-NTA agarose in lysis buffer+10 mM imidazole, the resin
was then washed in lysis buffer+20 mM imidazole and HIS-PAR-6 eluted in lysis
buffer+150 mM imidazole. Binding was performed with 1 μg of each protein, in 50 mM
Tris pH7.5, 150 mM NaCl, 0.5% Triton, 2 mM DTT, 1 mM EDTA, 10% glycerol and protease
cocktail inhibitor (Roche), 1 h at room temperature. Beads were washed 5 times in the
same buffer before adding sample buffer.
Results
We previously showed that loss of NOS-3 is able to suppress
par-2(it5) lethality and polarity defects (Labbe et al., 2006 and
Figs. 1A, B). We next sought to determine the mechanisms by which
nos-3(q650) suppresses par-2(it5) phenotypes. In the C. elegans
germline, NOS-3 has been proposed to repress the translation of
fem-3, a gene involved in sex determination (Hodgkin, 1986; Kraemer
et al., 1999). We therefore tested whether the suppression of par-2(it5)
phenotypes in nos-3(q650);par-2(it5) embryos depends on fem-3.
Indeed, suppression of par-2(it5) lethality was strongly reduced in
nos-3(q650);par-2(it5);fem-3(e2006) mutants (Fig. 1A). In addition,
the suppression of par-2(it5) polarity defects was also reduced inFig. 2. The FEM1/2/3 complex is required for the suppression of par-2(it5) lethality by nos-3
Drosophila S2 cells. Cells were transfected with HA-FEM-1, FLAG-FEM-2 and FLAG-FEM-3
anti-HA antibodies. Stars indicate the IgG band. (B–D) Inactivation of fem-1 (B), fem-2 (C), fem
(student t-test pb0.05) but not to increased lethality of nos-3(q650). The difference betwee
signiﬁcant. Lethality was assessed by counting more than 500 progeny of each genotype.nos-3(q650);par-2(it5);fem-3(e2006) when compared to nos-3
(q650);par-2(it5) embryos (Fig. 1B and legend). Moreover, FEM-3 is
also required to restore the asymmetric localization of PAR-6 in
nos-3(q650);par-2(it5) embryos (Fig. 1B). These data are consistent
with NOS-3 acting as a repressor of fem-3 and shows that FEM-3 is
required for the suppression of par-2(it5) phenotypes.
In the germline, two other fem genes, fem-1 and fem-2, behave
genetically like fem-3 (Hodgkin, 1986). Consistently, FEM-1, FEM-2
and FEM-3 form a complex (Fig. 2A and Starostina et al., 2007) and are
components of the CUL-2/ElonginB/C based ubiquitin ligase CBCFEM-1
(Starostina et al., 2007). We therefore asked whether the CBCFEM-1
ubiquitin ligase was required for the suppression of par-2(it5)
phenotypes by nos-3(q650). We inactivated fem-1 and fem-2 by RNAi
and found that RNAi to both fem-1 and fem-2 inhibits the suppression
of par-2(it5) embryonic lethality by nos-3(q650) (Figs. 2B, C and
legend for statistical analysis). Unfortunately we did not obtain triple
mutants with fem-1ts and fem-2ts mutant alleles. However, although
the effect of depleting fem-1 and fem-2 by RNAi was weaker than the
effect observed with the fem-3(e2006) mutant (Fig. 1A), it was
comparable to the effect observed with fem-3(RNAi) (Fig. 2D).
Furthermore, cul-2 behaves genetically similarly to the fem genes:
weak inactivation of cul-2 by RNAi that did not increase the embryonic
lethality of nos-3(q650) was sufﬁcient to inhibit the suppression of
par-2(it5) lethality by nos-3(q650) (Fig. 3A). The suppression of
par-2(it5) polarity defects is also reduced in nos-3(q650);par-2(it5)
cul-2(RNAi) embryos compared to nos-3(q650);par-2(it5) embryos
(Fig. 3B). This effect is speciﬁc to cul-2 since RNAi to cul-1 or cul-3
did not inhibit suppression of par-2(it5) lethality by nos-3(q650)
mutants (data not shown). Altogether, these results indicate that the(q650). (A) FEM-2 and FEM-3 coimmunoprecipitate with FEM-1 when coexpressed in
or only FLAG-FEM-2 and FLAG-FEM-3. Immunoprecipitations were performed with
-3 (D) by RNAi leads to signiﬁcant increased lethality of nos-3(q650);par-2(it5) embryos
n the lethality of par-2(it5) and par-2(it5);fem-1(RNAi) or par-2(it5)fem-2(RNAi) is not
Fig. 3. CUL-2 is required for the suppression of par-2(it5) lethality by nos-3(q650).
(A) Inactivation of cul-2 by RNAi leads to signiﬁcant increased lethality of nos-3(q650);
par-2(it5) embryos (student t-test pb0.05) but not to increased lethality of nos-3(q650).
Lethality was assessed by counting more than 500 progeny of each genotype. (B)
cul-2(RNAi) inhibits the suppression of par-2(it5) polarity defects such as symmetry of
division and absence of nucleo-centrosomal complex rotation in P1 by nos-3(q650).
Asynchrony of division is similar in nos-3(q650);par-2(it5) and nos-3(q650);par-2(it5)
cul-2(RNAi) embryos. Asymmetry in size, asynchrony of division and orientation of
the P1 spindle were measured as in Fig. 1B. Anterior is to the left.
Fig. 4. PAR-6 protein levels are reduced in nos-3(q650) embryos. (A–C) PAR-6 (A), but
not PKC-3 (B) and PAR-3 (C), levels are lower in nos-3(q650) than in wild-type embryos
(student t-test between wild-type and nos-3(q650) for PAR-6 pb0.001, for PKC-3 and
PAR-3 pN0.1).
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(it5) phenotypes by nos-3(q650).
Reducing the levels of the anterior PAR proteins has been shown to
suppress par-2 phenotypes (Labbe et al., 2006; Watts et al., 1996).
Moreover, our data show that the suppression of par-2(it5) pheno-
types by nos-3(q650) requires CUL-2, raising the possibility that the
suppression of par-2(it5) phenotypes by nos-3(q650) may be due to
the CUL-2 dependent degradation of one of the anterior PAR proteins.
We therefore tested whether the levels of the anterior PAR proteins
were reduced in nos-3(q650) embryos. Interestingly, western blot
analysis showed that PAR-6 levels were reduced in nos-3(q650)
embryos compared to wild-type embryos (Fig. 4A). Neither PKC-3 nor
PAR-3 levels were signiﬁcantly reduced in nos-3(q650) embryos (Figs.
4B, C). Therefore, NOS-3 positively regulates PAR-6 levels but not
PKC-3 and PAR-3 levels.
nos-3(q650) embryos have about half of the wild-type PAR-6 levels
(Fig. 4A), but no obvious polarity defects (Labbe et al., 2006), showing
that this reduction of PAR-6 levels is not sufﬁcient to result in par-6
phenotypes. Consistently, we also did not observe obvious polarity
defects in embryos from par-6(zu222+/−) heterozygous hermaphro-
dites (data not shown). However, like in par-6 heterozygous mutants,
which also suppress par-2 lethality (Watts et al., 1996), the reduction
of PAR-6 levels in nos-3(q650) mutants is most likely responsible for
the suppression of par-2(it5) lethality. To test this, we inactivatedpar-2 in a strain mutant for nos-3 but expressing higher total levels
of PAR-6 protein, resulting from the expression of both endogenous
PAR-6 and GFP::PAR-6 (nos-3(q650);pie-1::GFP::PAR-6) (Fig. 5B).
While embryonic lethality of par-2(RNAi) was strongly suppressed
in nos-3(q650) mutants, no signiﬁcant suppression was observed in
nos-3(q650);GFP::PAR-6 embryos (Fig. 5A). Although we cannot
exclude that regulation of other polarity factors by nos-3 also
contributes to the suppression of par-2 lethality, this result indicates
that the suppression is mainly due to the reduction of PAR-6 levels
observed in nos-3(q650) embryos.
Suppression of par-2(it5) lethality by nos-3(q650) mutants
requires both CUL-2 and reduction of PAR-6 levels, suggesting that
PAR-6 may be degraded in a CUL-2 dependent manner. We therefore
tested whether the reduction of PAR-6 levels in nos-3(q650) mutants
was dependent on CUL-2. Since cul-2(RNAi) embryos have early
embryonic defects (Liu et al., 2004; Sonneville and Gonczy, 2004)
they cannot directly be compared to control embryos. However,
we ﬁnd that while PAR-6 levels are reduced in nos-3(q650) compared
to wild-type embryos, they are equal in nos-3(q650) and wild-type
when cul-2 is inactivated (Fig. 6). This indicates that CUL-2 is required
for the reduction of PAR-6 levels in nos-3(q650) mutants and suggests
that PAR-6 can be degraded in a CUL-2 dependent manner.
To determine whether PAR-6 could be a direct substrate of the
CBCFEM-1 ubiquitin ligase, we tested whether PAR-6 interacts with
FEM-1, which has been shown to be the substrate-speciﬁc adaptor for
CBCFEM-1. When coexpressed in Drosophila S2 cells, FEM-1 co-
Fig. 6. Reduction of PAR-6 protein levels in nos-3(q650) embryos requires CUL-2. (A, B)
PAR-6 levels are lower in nos-3(q650) compared to wt embryos but the same in
nos-3(q650);cul-2(RNAi) compared to cul-2(RNAi) embryos (student t-test between
wt and nos-3(q650) pb0.001, between cul-2(RNAi) and nos-3(q650) pN0.1). The
experiments in panels A and B were performed in parallel and with the same
conditions (see Materials and methods).
Fig. 5. Reduction of PAR-6 levels in nos-3(q650) embryos is required for the suppression
of par-2 lethality. (A) Increased PAR-6 levels due to the expression of a GFP::PAR-6
transgene inhibit the suppression of par-2 lethality by nos-3(q650). (B) Total PAR-6
protein levels are higher in nos-3(q650);GFP::PAR-6 embryos compared to nos-3(q650)
embryos. Endogenous PAR-6 and GFP::PAR-6 were detected with anti-PAR-6 antibody.
The downregulation of endogenous PAR-6 levels observed in nos-3(q650);GFP::PAR-6
embryos compared to nos-3(q650) embryos is also observed in GFP::PAR-6 embryos
compared to wild-type embryos (data not shown). Bands shown were obtained from
nonadjacent lanes of the same blot.
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precipitates from control cells which did not express PAR-6 (Fig. 7A).
An unrelated protein, MEX-5, did not co-immunoprecipitate with
PAR-6 (Fig. 7A). Interestingly, FEM-3 and weakly FEM-2, also co-
immunoprecipitated with PAR-6 and FEM-1 (Fig. 7B). Bacterially
puriﬁed GST-FEM-1 was also able to interact in vitro with bacterially
puriﬁed HIS-PAR-6, while two other proteins, GST-MEX-5 (not shown)
and another CUL-2 substrate-speciﬁc adaptor, GST-ZIF-1 (Fig. 7C)
were not able to interact with PAR-6 in the same conditions. Alto-
gether our data suggest that PAR-6 is a substrate of the CBCFEM-1
ubiquitin ligase.
Discussion
Here we show that nos-3(q650) suppresses par-2(it5) lethality by
controlling PAR-6 levels. Our data also show that the suppression of
par-2(it5) phenotypes by nos-3(q650) requires FEM-1/2/3 and CUL-2.
Moreover, we ﬁnd that CUL-2 is required for the regulation of PAR-6
levels and that PAR-6 interacts with the substrate-speciﬁc adaptor
FEM-1, suggesting that PAR-6 is a substrate of the CBCFEM-1 ubiquitin
ligase.
Previous data suggested that NOS-3 represses fem-3 translation by
binding to the PUMILIO homologues, FBF-1 and FBF-2 (Kraemer et al.,
1999). We recently showed that fbf-1 and fbf-2 are also par-2
suppressors (Labbe et al., 2006) and we ﬁnd here that the suppression
of par-2(it5) phenotypes by nos-3(q650) requires the activity of fem-3.
Altogether, these data suggest that NOS-3 suppresses par-2(it5)
phenotypes by repressing fem-3 translation (Fig. 7D).
Work from the Kipreos lab has shown that FEM-3 forms a complex
with FEM-1, FEM-2 and the cullin CUL-2. FEM-1 has been shown to be
a substrate-speciﬁc adaptor for the CUL-2/ElonginB/C based ubiquitinligase CBCFEM-1 while FEM-2 and FEM-3 increase the activity of this
ubiquitin ligase when cotransfected in mammalian cells (Starostina et
al., 2007). Here we show that PAR-6 levels are regulated by NOS-3 in a
CUL-2 dependent manner. Consistently with PAR-6 regulation
occurring at the protein level, par-6 mRNA levels are unchanged in
nos-3 mutants (data not shown). Importantly, we also ﬁnd that the
substrate-speciﬁc adaptor FEM-1 physically interacts with PAR-6,
suggesting that the CBCFEM-1 ubiquitin ligase directly regulates PAR-6
degradation (Fig. 7D). However, we cannot exclude alternative
mechanisms involving indirect regulation of PAR-6 levels by the
CBCFEM-1 ubiquitin ligase. For instance CBCFEM-1 could degrade a
protein which is in turn essential for PAR-6 stability.
Where and when the regulation of PAR-6 levels occurs is so far not
known. One possibility is that the regulation of PAR-6 levels occurs in
the germline during late oogenesis. Alternatively, this regulation
could (also) occur in the embryo. If regulation of PAR-6 levels occurs
in the embryo, it would be of great interest to determine whether
PAR-6 regulation is uniform or asymmetric along the antero-posterior
axis. Indeed, asymmetric activity of the CBCFEM-1 ubiquitin ligase
could contribute to reinforce PAR-6 asymmetric distribution. Notably,
CUL-2, together with another substrate-speciﬁc adaptor, the protein
ZIF-1, has previously been shown to be active in the anterior blas-
tomere of the two-cell stage embryo where it degrades germline
proteins (DeRenzo et al., 2003). This raises the interesting possibility
that the asymmetric activity of different substrate-speciﬁc adaptors
allows CUL-2 to degrade speciﬁc substrates preferentially at the
anterior or the posterior of the embryo. A third substrate-speciﬁc
adaptor of CUL-2, ZYG-11, has been shown to participate in polarity
establishment by a so far unknown mechanism (Liu et al., 2004;
Sonneville and Gonczy, 2004). This emphasizes that CUL-2, via its
different substrate adaptors, regulates polarity of the early C. elegans
embryo at multiple levels.
In conclusion, our work shows that PAR-6 levels can be regulated
and that this regulation depends on the activity of a CUL-2 based
ubiquitin ligase. Thereby our work reveals a novel role for the FEM
Fig. 7. PAR-6 physically interacts with FEM-1. (A, B) FEM-1, FEM-2 and FEM-3 coimmunoprecipitate with PAR-6 when coexpressed in Drosophila S2 cells. In panel A, cells were
transfected with both HA-FEM-1 and PAR-6, or only HA-FEM-1, or HA-MEX-5 and PAR-6. In panel B, cells were transfected with HA-FEM-1, HA-FEM-2, HA-FEM-3 and PAR-6; or only
HA-FEM-1, HA-FEM-2 and HA-FEM-3. Immunoprecipitations were performed with anti-PAR-6 antibodies. Two speciﬁc bands are observed for HA-MEX-5, most likely due to
posttranslational modiﬁcations. Stars indicate the IgG band. (C) Bacterially puriﬁed GST-FEM-1, but not GST-ZIF-1, interacts in vitro with bacterially puriﬁed HIS-PAR-6. (D) Proposed
model for the regulation of PAR-6 levels by NOS-3: NOS-3 represses fem-3 translation and the CBCFEM-1 ubiquitin ligase negatively regulates PAR-6 levels most likely by targeting it for
proteasome dependent degradation. As mentioned in the Discussion, this regulation could also be indirect (as indicated by the dotted inhibitory line). PAR-6 and PAR-2 mutually
exclude each other from their respective cortices.
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